Crowther et al. found that 20 percent of women with GDM need antenatal insulin treatment (AIT) to achieve good glycemic control [6], while other studies also showed that 10.8~52.8 percent of GDM patients required AIT [7–11]. The gene discussed is INS; the disease is gestational diabetes.